RecruitingNot ApplicableNCT05657743

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer


Sponsor

Alpha Tau Medical LTD.

Enrollment

15 participants

Start Date

Aug 16, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a new type of targeted radiation called Alpha DaRT — tiny radioactive seeds inserted directly into a tumor — for people with advanced pancreatic cancer that has spread or cannot be surgically removed and has not responded to chemotherapy. **You may be eligible if...** - You have confirmed advanced or metastatic pancreatic cancer - You have already tried at least one chemotherapy regimen, or are medically unable to receive further chemotherapy - Your tumor cannot be surgically removed, or you have chosen not to have surgery - Your tumor is 5 cm or smaller and can be targeted by the seeds - You are 18 or older with an ECOG health status of 0–2 - Your life expectancy is more than 6 months **You may NOT be eligible if...** - You have never tried chemotherapy and are still eligible for it - Your tumor is too large or not technically accessible for seed placement - Your blood counts, organ function, or overall health do not meet minimum requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERadiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of radioactive sources \[Ra-224 containing stainless-steel 316LVM tubes- (Alpha DaRT seeds)\]. The seeds release by recoil into the tumor short-lived alpha-emitting atoms


Locations(2)

Wolfson Medical Center

Holon, Israel

Hadassah Ein Kerem

Jerusalem, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05657743


Related Trials